Black patients are dying waiting. They make up a disproportionate share of those desperately needing life-saving organ transplants, yet they continue to face persistent barriers rooted in deep-seated ...

Failure is endemic to clinical trials, with roughly 9 in 10 drug candidates not reaching market. But could virtual patients — vis-à-vis, synthetic data — make for more successful research questions?

This week, agentic AI steps into the limelight buoyed by the momentum from generative AI. And there’s a new virtual cell model in town courtesy of AI-drug developer Xaira Therapeutics. From the ...

Surgeons may one day be able to rehearse life-saving operations before even touching a patient. A mother donating part of her liver to her sick baby could, for example. undergo a safer, more ...